Search clinical trials for: anti-thymocyte globulin IV

Total 2590 results

Central Hospital, Nancy, France

Unknown

Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma (FNa-CHOLINE)

Bone Metastasis

France
King Chulalongkorn Memorial Hospital

Recruiting

High Dose Oral Omeprazole in High Risk UGIB

GI Bleeding

Thailand
Cairo University

Completed

Radiographic Assessment of Glass Ionomer Restorations With and Without Prior Application of Nano Silver Fluoride in Occlusal Carious Molars Treated With Partial Caries Removal Technique

Partial Dentin Caries Removal

Egypt
NYU Langone Health

Completed

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

Brugada Syndrome | Arrhythmogenic Right Ventricular Cardiomyopathy

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Novartis

Completed

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany, United States
Novartis

Completed

A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes

Diabetes Mellitus, Type 2
Novartis Pharmaceuticals

Completed

A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Switzerland
Sumithira Vasu

Completed

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions

United States
Yonsei University

Withdrawn

The Effects of Optimizing Post-operative Pain Management With Multi Modal Analgesia on Immune Suppression and Oncologic Outcome in Patients Undergoing Laparoscopic Colorectal Surgery

Laparoscopic Colorectal Resection Due to Cancer

Korea, Republic of
Rhode Island Hospital

Recruiting

Systemic Lidocaine Versus Ultrasound-guided Adductor Canal Block for Patients Undergoing Total Knee Arthroplasty (ACBSL)

Arthroplasty, Replacement, Knee | Total Knee Arthroplasty

United States
University Tunis El Manar

Active, not recruiting

Comparison of Erector Spinae Plane Block vs Intravenous Lidocaine for Chronic Pain Post Mastectomy.

Breast Surgery

Tunisia
Novartis Pharmaceuticals

Completed

Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Germany
Novartis

Completed

Efficacy and Safety of Vildagliptin as add-on Therapy to Insulin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
Novartis

Completed

Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

Switzerland
Novartis

Completed

Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance

Prediabetic State

United States
Novartis

Completed

Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients

Type 2 Diabetes Mellitus

Germany
Office of Rare Diseases (ORD)
Rare Diseases Clinical Research Network

Unknown

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Stony Brook University

Recruiting

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

Postpartum Hemorrhage

United States
Novartis

Completed

Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Philippines, India, Puerto Rico, Canada, Malaysia, Romania, Slovakia
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

TYpe 2 Diabetes Mellitus

India
Novartis

Completed

Efficacy and Safety of Three Doses of Vildagliptin in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Royal Devon and Exeter NHS Foundation Trust
Novartis Pharmaceuticals; National Institute for Health Research, United Kingdom

Completed

The Vascular Effects of Vildagliptin in Insulin Resistant Individuals

Insulin Resistance | Microvascular Disease

United Kingdom
Novartis

Completed

Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Novartis Pharmaceuticals

Completed

Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

Egypt
University of Campania "Luigi Vanvitelli"

Completed

DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes

Chronic Foot Ulcers

Italy
Novartis Pharmaceuticals

Completed

Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United Kingdom
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With HbA1c 9-11%

Diabetes Mellitus, Type 2

Switzerland
National Institute of Neurological Disorders and...

Completed

EMD 128130 for the Treatment of Parkinson's Disease

Parkinson's Disease

United States
Chung-Ang University Hosptial, Chung-Ang University...

Completed

The Effect of Intravenous Lidocaine on Pain After Lumbar Spinal Fusion

Postoperative Pain

Korea, Republic of
Chung-Ang University Hosptial, Chung-Ang University...

Unknown

The Effect of Intravenous Lidocaine on Pain After Tonsillectomy

Postoperative Pain

Korea, Republic of
Vancouver General Hospital
Heart and Stroke Foundation of Canada; Vancouver Coastal Health Research Institute

Completed

Aminophylline in Bradyasystolic Cardiac Arrest

Cardiac Arrest

Canada
Hamilton Health Sciences Corporation
McMaster University; Ontario Clinical Oncology Group (OCOG)

Recruiting

Infection Prophylaxis in Total Joint Replacement (PREVENT-iT)

Periprosthetic Joint Infection

Canada
Novartis Pharmaceuticals

Completed

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Diabetes Mellitus, Type 2

United States, Germany
Cubist Pharmaceuticals LLC

Completed

Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008) (ASPECT-NP)

Lung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
Hospital do Coracao
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital Sirio-Libanes and other collaborators

Completed

Daily Chlorexidine Bath for Health Care Associated Infection Prevention (CLEAN-IT)

Ventilator Associated Pneumonia | Health Care Associated Infection | Catheter-Associated Urinary Tract Infection | Central Line-associated Bloodstream Infection (CLABSI)

Brazil
University of Padova
IL Sogno di Stefano; Regione Veneto

Terminated

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

Urinary Tract Infections
King Abdul Aziz Specialist Hospital

Completed

Entral Feeding in Acute Severe Pancreatitis

Postoperative Nausea

Saudi Arabia
Novartis Pharmaceuticals

Completed

Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.

Type II Diabetes Mellitus

Germany
Seoul National University Bundang Hospital

Completed

Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin

Diabetes

Korea, Republic of
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Novartis

Terminated

Assessment of the Skin-concentration of Vildagliptin 50 mg Every 12 Hours for 10 Days in Healthy Subjects and Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Johann Wolfgang Goethe University Hospital

Withdrawn

Functional Improvement of Progenitor Cells and Endothelial Function by Vildagliptin in Diabetes Mellitus (FINNjA-DM). (FINNjA-DM)

SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors

Germany
Novartis

Completed

Vildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Mellitus, Type 2

Germany
Novartis

Completed

Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Germany
Novartis

Completed

A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2
Novartis

Completed

Safety, Tolerability, Effect of Vildagliptin and How the Body Changes the Blood Level of Vildagliptin in Healthy Chinese Volunteers

Healthy

China

3

Subscribe